Oesophageal Cancer Trial, Recruiting NCT04306458 Sponsor: University Medical Center Mainz Condition: Oesophageal Cancer
Back to Oesophageal Cancer

Oesophageal Cancer Trial, Recruiting

NCT04306458
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with a specific type of cancer (called adenocarcinoma) in the esophagus (food pipe) or where the esophagus meets the stomach, confirmed by a tissue sample test
  • Your cancer is considered operable (able to be removed by surgery) and has not spread to distant parts of the body
  • You are between 18 and 90 years old
  • You are reasonably well and able to carry out daily activities, even if you have some limitations due to your condition (confirm with trial site)
  • You are willing and able to give written consent to take part in the trial

Who may not be able to join:

  • Your esophageal cancer is a different type, called squamous cell carcinoma
  • Your cancer is located in the uppermost part of the esophagus, in the neck area
  • Your cancer is at the junction of the esophagus and stomach, but the main bulk of the tumor is in the upper stomach area (known as Siewert type III)
  • You have previously had surgery on the right side of your chest, or have had a significant injury to your chest in the past

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Peter Grimminger, MD,PhD, JGU Medizin Mainz, dept. AVTC

Phone: +31628880709

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Medical Center Mainz
Registry
ClinicalTrials.gov
Start date
18 January 2021
Est. completion
19 May 2023

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Total number of dissected lymph nodes

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov